(FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q9)Sep 30, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 10.82%406.03B | 18.00%285.31B | 21.37%192.12B | 24.19%88.52B | 13.68%366.4B | 15.36%241.78B | 11.83%158.29B | --71.28B | 19.23%322.32B | --209.59B |
Operating income | 10.82%406.03B | 18.00%285.31B | 21.37%192.12B | 24.19%88.52B | 13.68%366.4B | 15.36%241.78B | 11.83%158.29B | 71.28B | 19.23%322.32B | 209.59B |
Operating expenses | -10.54%-354.73B | -17.38%-254.07B | -20.25%-171.12B | -24.75%-79.61B | -14.64%-320.89B | -17.78%-216.45B | -14.39%-142.3B | -63.82B | -19.82%-279.91B | -183.77B |
Gross profit | 12.75%51.31B | 23.29%31.24B | 31.37%21B | 19.36%8.91B | 7.30%45.5B | -1.86%25.34B | -6.76%15.99B | 7.46B | 15.47%42.41B | 25.82B |
Selling expenses | -12.63%-1.9B | -8.69%-1.29B | -13.29%-839.51M | -0.11%-396.7M | -1.19%-1.69B | 2.51%-1.19B | 6.87%-741.04M | ---396.26M | -13.33%-1.67B | ---1.22B |
Administrative expenses | -7.51%-14.75B | -12.95%-10.37B | -13.95%-6.81B | -13.79%-3.46B | -7.65%-13.72B | -2.72%-9.18B | 3.46%-5.97B | ---3.04B | -10.31%-12.75B | ---8.94B |
Research and development expenses | -24.31%-12.98B | -38.10%-6.92B | -41.59%-4.17B | -39.58%-1.29B | -18.80%-10.44B | -32.10%-5.01B | -21.26%-2.94B | ---921.9M | -29.55%-8.79B | ---3.79B |
Profit from asset sales | -57.45%304.97M | -80.89%85.82M | -66.29%57.63M | -34.69%47.53M | -11.51%716.68M | 13.72%449.2M | -55.98%170.97M | --72.77M | 87.14%809.9M | --395M |
Revaluation surplus | 363.82%331.11M | 25.50%29.47M | 228.97%7.04M | 325.43%4.72M | 777.10%71.39M | 552.11%23.48M | -379.04%-5.46M | ---2.09M | -98.57%8.14M | ---5.19M |
-Changes in the fair value of other assets | 363.82%331.11M | 25.50%29.47M | 228.97%7.04M | 325.43%4.72M | 777.10%71.39M | 552.11%23.48M | -379.04%-5.46M | ---2.09M | -98.57%8.14M | ---5.19M |
Impairment and provision | -28.16%-3.23B | -92.63%-736M | -215.89%-675.32M | -73.64%10.87M | -36.19%-2.52B | -55.64%-382.07M | -0.11%-213.78M | --41.25M | -6.04%-1.85B | ---245.48M |
-Other impairment is provision | -28.16%-3.23B | -92.63%-736M | -215.89%-675.32M | -73.64%10.87M | -36.19%-2.52B | -55.64%-382.07M | -0.11%-213.78M | --41.25M | -6.04%-1.85B | ---245.48M |
Special items of operating profit | -50.43%1.07B | -87.22%229.32M | -89.37%164.81M | -65.57%75.12M | 42.06%2.15B | 354.55%1.79B | 313.53%1.55B | --218.21M | -17.51%1.51B | --394.62M |
Adjustment items of operating profit | ---- | ---1K | ---- | 200.00%1K | ---- | ---- | ---- | ---1K | ---- | ---- |
Operating profit | 1.96%18.73B | 3.70%11.35B | 12.23%8.14B | 12.85%3.61B | 0.65%18.37B | -5.27%10.94B | -5.72%7.25B | 3.2B | 11.86%18.25B | 11.55B |
Financing cost | -1.40%-4.68B | -25.86%-3.4B | -12.82%-2.18B | -35.84%-1.12B | -25.68%-4.62B | 7.24%-2.7B | -5.14%-1.93B | ---825.92M | 3.16%-3.67B | ---2.91B |
Special items of earning before tax | 52.22%-35.49M | -159.66%-236.55M | 166.33%40.16M | 141.39%27.22M | 95.13%-74.29M | -227.39%-91.1M | -432.10%-60.55M | ---65.77M | -217.78%-1.53B | --71.52M |
Earning before tax | 2.44%14.01B | -5.38%7.71B | 14.08%6B | 9.01%2.52B | 4.80%13.68B | -6.44%8.15B | -10.45%5.26B | 2.31B | 8.39%13.05B | 8.71B |
Tax | 15.36%-2.76B | -4.12%-1.98B | -23.59%-1.46B | -26.83%-668.97M | 5.73%-3.25B | 14.68%-1.9B | 20.83%-1.18B | ---527.46M | -1.46%-3.45B | ---2.23B |
After-tax profit from continuing operations | 8.00%11.26B | -8.29%5.73B | 11.31%4.53B | 3.74%1.85B | 8.59%10.42B | -3.59%6.25B | -6.90%4.07B | 1.78B | 11.12%9.6B | 6.48B |
Special items of earning after tax | ---- | ---- | ---- | --1K | ---- | ---- | ---- | ---- | ---- | ---- |
Adjustment items of earning after tax | ---- | ---- | ---- | ---1K | ---- | ---- | ---- | ---- | ---- | ---- |
Earning after tax | 8.00%11.26B | -8.29%5.73B | 11.31%4.53B | 3.74%1.85B | 8.59%10.42B | -3.59%6.25B | -6.90%4.07B | 1.78B | 11.12%9.6B | 6.48B |
Minority profit | 25.84%3.27B | 29.39%2.65B | 48.25%1.88B | -12.72%717.16M | -16.01%2.6B | -34.19%2.05B | -37.39%1.27B | --821.69M | -22.01%3.09B | --3.12B |
Profit attributable to shareholders | 2.07%7.99B | -26.72%3.07B | -5.34%2.66B | 17.83%1.13B | 20.30%7.82B | 24.80%4.19B | 19.28%2.81B | 960.17M | 39.26%6.5B | 3.36B |
Basic earnings per share | 0.00%0.18 | -22.22%0.07 | 0.00%0.06 | 19.05%0.025 | -5.26%0.18 | -10.00%0.09 | -25.00%0.06 | 0.021 | 26.67%0.19 | 0.1 |
Diluted earnings per share | 0.00%0.18 | -22.22%0.07 | 0.00%0.06 | 19.05%0.025 | -5.26%0.18 | -10.00%0.09 | -25.00%0.06 | 0.021 | 26.67%0.19 | 0.1 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- |
Auditor | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership), Xinyong Zhonghe Certified Public Accountants (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data